[
  {
    "ts": null,
    "headline": "Winners And Losers Of Q2: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Drug Development Inputs & Services Stocks",
    "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Charles River Laboratories (NYSE:CRL) and its peers.",
    "url": "https://finnhub.io/api/news?id=1a71f4ed4a382d577962778ff48ea1e378e25bf309628832818715d8b70552e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759980840,
      "headline": "Winners And Losers Of Q2: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Drug Development Inputs & Services Stocks",
      "id": 137028636,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Charles River Laboratories (NYSE:CRL) and its peers.",
      "url": "https://finnhub.io/api/news?id=1a71f4ed4a382d577962778ff48ea1e378e25bf309628832818715d8b70552e4"
    }
  }
]